Core Viewpoint - The China Securities Hong Kong Stock Connect Medical and Health Comprehensive Index (Hong Kong Stock Connect Medical C, 930965) has shown significant growth, with a 20.91% increase over the past month, 43.59% over the past three months, and an impressive 80.61% year-to-date [1]. Group 1: Index Performance - The index opened low but closed higher, with a current value of 3666.44 points and a trading volume of 17.976 billion yuan [1]. - The index is designed to reflect the overall performance of 50 liquid and large-cap medical and health industry listed companies within the Hong Kong Stock Connect framework [1]. Group 2: Index Composition and Adjustments - The index is based on a starting point of 3000.0 points as of November 14, 2014, and undergoes biannual adjustments to its sample companies every June and December [1]. - Weight factors are generally fixed until the next scheduled adjustment, with special circumstances allowing for temporary adjustments [1].

Core Viewpoint - The China Securities Index for Hong Kong Stock Connect Medical and Health Comprehensive Index has shown significant growth, with a year-to-date increase of 85.26% [1]. Group 1: Index Performance - The Shanghai Composite Index decreased by 0.37%, while the Hong Kong Stock Connect Medical and Health Comprehensive Index fell by 2.51%, closing at 3658.84 points with a trading volume of 24.507 billion yuan [1]. - Over the past month, the Hong Kong Stock Connect Medical and Health Comprehensive Index has risen by 24.02%, and over the last three months, it has increased by 47.29% [1]. Group 2: Index Composition - The index comprises 50 liquid and large-cap medical and health industry companies listed within the Hong Kong Stock Connect, reflecting the overall performance of these securities [1]. - The index was established on November 14, 2014, with a base point of 3000.0 [1]. Group 3: Top Holdings - The top ten holdings in the index are as follows: - Innovent Biologics (10.25%) - WuXi Biologics (9.23%) - BeiGene (8.95%) - CanSino Biologics (8.12%) - China Biologic Products (5.97%) - CSPC Pharmaceutical Group (5.77%) - JD Health (4.52%) - 3SBio (4.19%) - Hansoh Pharmaceutical (3.0%) - WuXi AppTec (2.85%) [1]. Group 4: Market and Sector Allocation - The index's holdings are entirely composed of securities listed on the Hong Kong Stock Exchange, with a 100% allocation to the medical and health sector [1].

Group 1 - The core viewpoint of the article highlights the performance of the CSI Hong Kong Stock Connect Healthcare Index, which rose by 3.3% to 2878.7 points, with a trading volume of 21.443 billion yuan [1] - The CSI Hong Kong Stock Connect Healthcare Index has increased by 7.16% over the past month, 18.59% over the past three months, and 37.56% year-to-date [1] - The index consists of 50 liquid and large-cap healthcare companies listed within the Hong Kong Stock Connect, reflecting the overall performance of these securities [1] Group 2 - The index is adjusted semi-annually, with sample adjustments occurring on the next trading day after the second Friday of June and December each year [1] - The weight factors are generally fixed until the next scheduled adjustment, with special circumstances allowing for temporary adjustments [1] - The index will be adjusted if any securities no longer meet the connectivity qualifications due to changes in the Hong Kong Stock Connect [1] Group 3 - Public funds tracking the CSI Hong Kong Stock Connect Healthcare Index include various funds from E Fund, Ping An, and Yinhua, among others [2]

Core Viewpoint - The China Securities Hong Kong Stock Connect Medical and Health Comprehensive Index (Hong Kong Stock Connect Medical C, 930965) experienced a decline of 0.86%, closing at 2467.33 points, with a trading volume of 7.663 billion yuan. Despite this, the index has shown positive growth over various time frames, including a 2.33% increase over the past month, a 10.35% increase over the past three months, and a year-to-date increase of 22.86% [1]. Group 1 - The index is composed of 50 liquid and large-cap listed companies in the medical and health sector within the Hong Kong Stock Connect framework, reflecting the overall performance of these securities [1]. - The base date for the index is November 14, 2014, with a base point of 3000.0 [1]. - The index samples are adjusted biannually, with adjustments occurring on the next trading day after the second Friday of June and December each year [1]. Group 2 - Public funds tracking the Hong Kong Stock Connect Medical C include various funds from E Fund, Ping An, and Yinhua, among others, indicating a diverse interest in this index [2].